Integrated Biopharma INBP
OTC INBP
$0.18 +0.02 (+12.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Integrated Biopharma (INBP) Convertible Debt (2012 - 2013)

Updated

Integrated Biopharma (INBP) posted Convertible Debt of $4.9 million for fiscal Q4 2013 (quarter ended Jun 30, 2013), up 2.2% from $4.8 million a year earlier.

Analysis

Integrated Biopharma (INBP) Convertible Debt (2012 - 2013) Analysis & Trends

  • In prior fiscal years, Integrated Biopharma's Convertible Debt was $4.8 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 336.76 Bn 292.75 Bn 10.28 Bn
2 Colgate Palmolive 67.18 Bn 62.24 Bn 3.30 Bn
3 Estee Lauder Companies 33.32 Bn 21.40 Bn 2.74 Bn
4 Kenvue 33.09 Bn 28.70 Bn 2.30 Bn
5 Kimberly Clark 31.38 Bn 28.71 Bn 1.60 Bn
6 Church & Dwight 22.37 Bn 20.90 Bn 693.90 Mn
7 Clorox 9.72 Bn 8.16 Bn 804.00 Mn
8 e.l.f. Beauty 6.17 Bn 5.15 Bn 398.84 Mn
9 Reynolds Consumer Products 4.71 Bn 4.37 Bn 245.00 Mn
10 Integrated Biopharma 5.59 Mn -14.75 Mn 28,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 4.90 Mn
Jun 30, 2012 4.80 Mn
API Access

Integrated Biopharma Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=INBP&period=max&api_key=YOUR_API_KEY